vs

Side-by-side financial comparison of CareCloud, Inc. (CCLD) and INSEEGO CORP. (INSG). Click either name above to swap in a different company.

INSEEGO CORP. is the larger business by last-quarter revenue ($48.4M vs $34.4M, roughly 1.4× CareCloud, Inc.). On growth, CareCloud, Inc. posted the faster year-over-year revenue change (21.9% vs 0.6%). INSEEGO CORP. produced more free cash flow last quarter ($11.6M vs $6.6M). Over the past eight quarters, CareCloud, Inc.'s revenue compounded faster (15.1% CAGR vs 13.6%).

CareCloud, Inc. is a publicly traded American healthcare information technology company that provides services, to healthcare providers and hospitals. The Company maintains its headquarters in Somerset, New Jersey, and employs approximately 4,000 workers worldwide.

Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.

CCLD vs INSG — Head-to-Head

Bigger by revenue
INSG
INSG
1.4× larger
INSG
$48.4M
$34.4M
CCLD
Growing faster (revenue YoY)
CCLD
CCLD
+21.2% gap
CCLD
21.9%
0.6%
INSG
More free cash flow
INSG
INSG
$5.1M more FCF
INSG
$11.6M
$6.6M
CCLD
Faster 2-yr revenue CAGR
CCLD
CCLD
Annualised
CCLD
15.1%
13.6%
INSG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCLD
CCLD
INSG
INSG
Revenue
$34.4M
$48.4M
Net Profit
$469.0K
Gross Margin
42.2%
Operating Margin
9.1%
2.7%
Net Margin
1.0%
Revenue YoY
21.9%
0.6%
Net Profit YoY
182.9%
EPS (diluted)
$0.06
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCLD
CCLD
INSG
INSG
Q4 25
$34.4M
$48.4M
Q3 25
$31.1M
$45.9M
Q2 25
$27.4M
$40.2M
Q1 25
$27.6M
$31.7M
Q4 24
$28.2M
$48.1M
Q3 24
$28.5M
$54.0M
Q2 24
$28.1M
$51.6M
Q1 24
$26.0M
$37.5M
Net Profit
CCLD
CCLD
INSG
INSG
Q4 25
$469.0K
Q3 25
$3.1M
$1.4M
Q2 25
$2.9M
$507.0K
Q1 25
$1.9M
$-1.6M
Q4 24
$-566.0K
Q3 24
$3.1M
$9.0M
Q2 24
$1.7M
$624.0K
Q1 24
$-241.0K
$-4.5M
Gross Margin
CCLD
CCLD
INSG
INSG
Q4 25
42.2%
Q3 25
41.6%
Q2 25
41.1%
Q1 25
47.3%
Q4 24
37.3%
Q3 24
34.8%
Q2 24
36.4%
Q1 24
35.3%
Operating Margin
CCLD
CCLD
INSG
INSG
Q4 25
9.1%
2.7%
Q3 25
10.3%
4.7%
Q2 25
10.9%
3.2%
Q1 25
7.3%
-1.3%
Q4 24
12.2%
3.7%
Q3 24
11.4%
1.9%
Q2 24
8.1%
3.6%
Q1 24
0.5%
-7.9%
Net Margin
CCLD
CCLD
INSG
INSG
Q4 25
1.0%
Q3 25
9.8%
3.1%
Q2 25
10.6%
1.3%
Q1 25
7.0%
-5.0%
Q4 24
-1.2%
Q3 24
10.9%
16.6%
Q2 24
6.0%
1.2%
Q1 24
-0.9%
-11.9%
EPS (diluted)
CCLD
CCLD
INSG
INSG
Q4 25
$0.06
$-0.02
Q3 25
$0.04
$0.03
Q2 25
$0.04
$-0.03
Q1 25
$-0.04
$-0.16
Q4 24
$0.00
$0.62
Q3 24
$-0.04
$-0.06
Q2 24
$-0.14
$-0.02
Q1 24
$-0.10
$-0.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCLD
CCLD
INSG
INSG
Cash + ST InvestmentsLiquidity on hand
$24.9M
Total DebtLower is stronger
$1.2M
Stockholders' EquityBook value
$59.5M
$-4.0M
Total Assets
$87.6M
$93.8M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCLD
CCLD
INSG
INSG
Q4 25
$24.9M
Q3 25
$14.6M
Q2 25
$13.2M
Q1 25
$35.1M
Q4 24
$39.6M
Q3 24
$12.0M
Q2 24
$49.0M
Q1 24
$12.3M
Total Debt
CCLD
CCLD
INSG
INSG
Q4 25
$1.2M
Q3 25
Q2 25
Q1 25
Q4 24
$336.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CCLD
CCLD
INSG
INSG
Q4 25
$59.5M
$-4.0M
Q3 25
$57.8M
$-7.7M
Q2 25
$56.1M
$-10.5M
Q1 25
$54.2M
$-13.0M
Q4 24
$49.8M
$-12.9M
Q3 24
$46.5M
$-85.1M
Q2 24
$43.2M
$-101.8M
Q1 24
$41.4M
$-105.6M
Total Assets
CCLD
CCLD
INSG
INSG
Q4 25
$87.6M
$93.8M
Q3 25
$90.6M
$85.8M
Q2 25
$75.2M
$83.1M
Q1 25
$73.6M
$93.0M
Q4 24
$71.6M
$100.0M
Q3 24
$70.7M
$113.4M
Q2 24
$74.0M
$149.6M
Q1 24
$76.9M
$122.1M
Debt / Equity
CCLD
CCLD
INSG
INSG
Q4 25
0.02×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCLD
CCLD
INSG
INSG
Operating Cash FlowLast quarter
$8.7M
$12.0M
Free Cash FlowOCF − Capex
$6.6M
$11.6M
FCF MarginFCF / Revenue
19.0%
24.0%
Capex IntensityCapex / Revenue
6.2%
0.7%
Cash ConversionOCF / Net Profit
25.50×
TTM Free Cash FlowTrailing 4 quarters
$23.8M
$6.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCLD
CCLD
INSG
INSG
Q4 25
$8.7M
$12.0M
Q3 25
$7.4M
$3.2M
Q2 25
$7.4M
$-4.5M
Q1 25
$5.1M
$-3.5M
Q4 24
$5.2M
$-14.2M
Q3 24
$7.1M
$14.8M
Q2 24
$4.3M
$27.6M
Q1 24
$4.1M
$5.2M
Free Cash Flow
CCLD
CCLD
INSG
INSG
Q4 25
$6.6M
$11.6M
Q3 25
$6.5M
$3.1M
Q2 25
$6.2M
$-4.7M
Q1 25
$4.5M
$-3.5M
Q4 24
$4.3M
$-14.3M
Q3 24
$6.7M
$14.8M
Q2 24
$4.2M
$27.6M
Q1 24
$3.8M
FCF Margin
CCLD
CCLD
INSG
INSG
Q4 25
19.0%
24.0%
Q3 25
20.9%
6.7%
Q2 25
22.8%
-11.6%
Q1 25
16.2%
-11.0%
Q4 24
15.2%
-29.7%
Q3 24
23.6%
27.4%
Q2 24
14.8%
53.5%
Q1 24
14.5%
Capex Intensity
CCLD
CCLD
INSG
INSG
Q4 25
6.2%
0.7%
Q3 25
2.8%
0.2%
Q2 25
4.2%
0.5%
Q1 25
2.3%
0.1%
Q4 24
3.3%
0.1%
Q3 24
1.2%
0.0%
Q2 24
0.5%
0.0%
Q1 24
1.1%
0.0%
Cash Conversion
CCLD
CCLD
INSG
INSG
Q4 25
25.50×
Q3 25
2.41×
2.22×
Q2 25
2.55×
-8.81×
Q1 25
2.62×
Q4 24
Q3 24
2.26×
1.65×
Q2 24
2.56×
44.31×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCLD
CCLD

Healthcare IT$31.0M90%
Medical Practice Management$3.4M10%

INSG
INSG

Segment breakdown not available.

Related Comparisons